Erratum: Microsatellite instability in colorectal cancer: From molecular oncogenic mechanisms to clinical implications (Cellular Oncology DOI: 10.1007/s13402-011-0024-x);Microsatellite instability in colorectal cancer: From molecular oncogenic mechanisms to clinical implications

Cellular Oncology

Volumn 34, Issue 3, 2011, Pages 155-176

  Zaanan, Aziz ^a,b,c   Meunier, Katy ^a,b,d   Sangar, Fatiha ^a,b   Fléjou, Jean François ^a,b,c   Praz, Françoise ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d CENTRE PAUL PAPIN   (France)

Author keywords

Biomarker; Chemotherapy; Colorectal cancer; Microsatellite instability; Mismatch repair; Prognosis

Indexed keywords

ACTIVIN RECEPTOR 2; ANTINEOPLASTIC AGENT; BRCA2 PROTEIN; CAPECITABINE; CASPASE 5; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HISTONE DEACETYLASE 2; IRINOTECAN; MISMATCH REPAIR PROTEIN PMS2; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 10; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; COLORECTAL CANCER; DNA DAMAGE; DNA METHYLATION; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; ARTICLE; CELL DEATH; COLORECTAL TUMOR; DRUG EFFECT; GENETICS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CELL DEATH; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; HUMANS; MICROSATELLITE INSTABILITY; PHENOTYPE;

EID: 82555177995     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0050-8     Document Type: Erratum

References (204)

1. L.A. Aaltonen, P. Peltomaki, F.S. Leach, P. Sistonen, L. Pylkkanen, J.P. Mecklin, H. Jarvinen, S.M. Powell, J. Jen, S.R. Hamilton et al., Clues to the pathogenesis of familial colorectal cancer. Science 260, 812-816 (1993) (Pubitemid 23167611)
2. M. Aarnio, J.P. Mecklin, L.A. Aaltonen, M. Nystrom-Lahti, H.J. Jarvinen, Life-Time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer 64, 430-433 (1995) (Pubitemid 26048907)
3. J. Abubaker, P. Bavi, S. Al-Harbi, M. Ibrahim, A.K. Siraj, N. Al-Sanea, A. Abduljabbar, L.H. Ashari, S. Alhomoud, F. Al-Dayel, S. Uddin, K.S. Al-Kuraya, Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene 27, 3539-3545 (2008) (Pubitemid 351793794)
4. S. Acharya, T. Wilson, S. Gradia, M.F. Kane, S. Guerrette, G.T. Marsischky, R. Kolodner, R. Fishel, hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl Acad. Sci. USA 93, 13629-13634 (1996) (Pubitemid 26424170)
5. S. Aebi, B. Kurdi-Haidar, R. Gordon, B. Cenni, H. Zheng, D. Fink, R.D. Christen, C.R. Boland, M. Koi, R. Fishel, S.B. Howell, Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56, 3087-3090 (1996) (Pubitemid 26199755)
6. E. Alani, The Saccharomyces cerevisiae Msh2 and Msh6 proteins form a complex that specifically binds to duplex oligonucleotides containing mismatched DNA base pairs. Mol. Cell. Biol. 16, 5604-5615 (1996) (Pubitemid 26315080)
7. D.J. Allen, A. Makhov, M. Grilley, J. Taylor, R. Thresher, P. Modrich, J.D. Griffith, MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J. 16, 4467-4476 (1997) (Pubitemid 27298200)
8. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, C. Topham, M. Zaninelli, P. Clingan, J. Bridgewater, I. Tabah-Fisch, A. de Gramont, Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350, 2343-2351 (2004) (Pubitemid 38702845)
9. T. Andre, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, A. Bonetti, P. Clingan, J. Bridgewater, F. Rivera, A. de Gramont, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J. Clin. Oncol. 27, 3109-3116 (2009)
10. C.N. Arnold, A. Goel, C.R. Boland, Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int. J. Cancer 106, 66-73 (2003) (Pubitemid 36750389)
11. S. Bader, M. Walker, B. Hendrich, A. Bird, C. Bird, M. Hooper, A. Wyllie, Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18, 8044-8047 (1999) (Pubitemid 30050565)
12. C. Ban, M. Junop, W. Yang, Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 97, 85-97 (1999) (Pubitemid 29165892)
13. R.A. Barnetson, A. Tenesa, S.M. Farrington, I.D. Nicholl, R. Cetnarskyj, M.E. Porteous, H. Campbell, M.G. Dunlop, Identification and survival of carriers of mutations in DNA mismatchrepair genes in colon cancer. N. Engl. J. Med. 354, 2751-2763 (2006) (Pubitemid 43974193)
14. P. Benatti, R. Gafa, D. Barana, M. Marino, A. Scarselli, M. Pedroni, I. Maestri, L. Guerzoni, L. Roncucci, M. Menigatti, B. Roncari, S. Maffei, G. Rossi, G. Ponti, A. Santini, L. Losi, C. Di Gregorio, C. Oliani, M. Ponz de Leon, G. Lanza, Microsatellite instability and colorectal cancer prognosis. Clin. Cancer Res. 11, 8332-8340 (2005) (Pubitemid 41746945)
15. M.J. Berends, Y. Wu, R.H. Sijmons, R.G. Mensink, T. van der Sluis, J.M. Hordijk-Hos, E.G. de Vries, H. Hollema, A. Karrenbeld, C.H. Buys, A.G. van der Zee, R.M. Hofstra, J.H. Kleibeuker, Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am. J. Hum. Genet. 70, 26-37 (2002) (Pubitemid 34031695)
16. M.M. Bertagnolli, D. Niedzwiecki, C.C. Compton, H.P. Hahn, M. Hall, B. Damas, S.D. Jewell, R.J. Mayer, R.M. Goldberg, L. B. Saltz, R.S. Warren, M. Redston, Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J. Clin. Oncol. 27, 1814-1821 (2009)
17. C.R. Boland, A. Goel, Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073-2087 (2010). e2073
18. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, S.J. Meltzer, M.A. Rodriguez-Bigas, R. Fodde, G.N. Ranzani, S. Srivastava, A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 (1998) (Pubitemid 28521189)
19. P. Branch, G. Aquilina, M. Bignami, P. Karran, Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362, 652-654 (1993) (Pubitemid 23109278)
20. R.A. Bras-Goncalves, C. Rosty, P. Laurent-Puig, P. Soulie, B. Dutrillaux, M.F. Poupon, Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status. Br. J. Cancer 82, 913-923 (2000) (Pubitemid 30085246)
21. C.E. Bronner, S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith, M.K. Lescoe, M. Kane, C. Earabino, J. Lipford, A. Lindblom et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-261 (1994)
22. W.M. Brueckl, C. Moesch, T. Brabletz, C. Koebnick, C. Riedel, A. Jung, S. Merkel, S. Schaber, F. Boxberger, T. Kirchner, W. Hohenberger, E.G. Hahn, A. Wein, Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy. Anticancer Res. 23, 1773-1777 (2003) (Pubitemid 36750847)
23. A. Buckowitz, H.P. Knaebel, A. Benner, H. Blaker, J. Gebert, P. Kienle, M. von Knebel Doeberitz, M. Kloor, Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br. J. Cancer 92, 1746-1753 (2005) (Pubitemid 40756487)
24. O. Buhard, F. Cattaneo, Y.F. Wong, S.F. Yim, E. Friedman, J.F. Flejou, A. Duval, R. Hamelin, Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J. Clin. Oncol. 24, 241-251 (2006) (Pubitemid 46622053)
25. B.M. Buttin, M.A. Powell, D.G. Mutch, S.A. Babb, P.C. Huettner, T.B. Edmonston, T.J. Herzog, J.S. Rader, R.K. Gibb, A.J. Whelan, P.J. Goodfellow, Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am. J. Hum. Genet. 74, 1262-1269 (2004) (Pubitemid 38669325)
26. C. Campregher, T. Scharl, M. Nemeth, C. Honeder, T. Jascur, C. R. Boland, C. Gasche, The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells. Hum. Mol. Genet. 19, 2648-2657 (2010)
27. E. Cannavo, G. Marra, J. Sabates-Bellver, M. Menigatti, S.M. Lipkin, F. Fischer, P. Cejka, J. Jiricny, Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res. 65, 10759-10766 (2005) (Pubitemid 41713344)
28. J.M. Carethers, D.P. Chauhan, D. Fink, S. Nebel, R.S. Bresalier, S.B. Howell, C.R. Boland, Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 117, 123-131 (1999) (Pubitemid 29297628)
29. J.M. Carethers, E.J. Smith, C.A. Behling, L. Nguyen, A. Tajima, R.T. Doctolero, B.L. Cabrera, A. Goel, C.A. Arnold, K. Miyai, C.R. Boland, Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 126, 394-401 (2004) (Pubitemid 38182296)
30. P. Cejka, L. Stojic, N. Mojas, A.M. Russell, K. Heinimann, E. Cannavo, M. di Pietro, G. Marra, J. Jiricny, Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 22, 2245-2254 (2003) (Pubitemid 36565547)
31. D.K. Chang, L. Ricciardiello, A. Goel, C.L. Chang, C.R. Boland, Steady-state regulation of the human DNA mismatch repair system. J. Biol. Chem. 275, 18424-18431 (2000) (Pubitemid 30414800)
32. N. Chaput, S. Louafi, A. Bardier, F. Charlotte, J.C. Vaillant, F. Menegaux, M. Rosenzwajg, F. Lemoine, D. Klatzmann, J. Taieb, Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58, 520-529 (2009)
33. N.W. Chi, R.D. Kolodner, Purification and characterization of MSH1, a yeast mitochondrial protein that binds to DNA mismatches. J. Biol. Chem. 269, 29984-29992 (1994) (Pubitemid 24365169)
34. S.W. Choi, K.J. Lee, Y.A. Bae, K.O. Min, M.S. Kwon, K.M. Kim, M.G. Rhyu, Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin. Cancer Res. 8, 2311-2322 (2002) (Pubitemid 34753606)
35. W. Chua, D. Goldstein, C.K. Lee, H. Dhillon, M. Michael, P. Mitchell, S.J. Clarke, B. Iacopetta, Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. Br. J. Cancer 101, 998-1004 (2009)
36. H. Chung, C.G. Lopez, J. Holmstrom, D.J. Young, J.F. Lai, D. Ream-Robinson, J.M. Carethers, Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair. Hum. Mol. Genet. 19, 2638-2647 (2010)
37. H. Chung, C.G. Lopez, D.J. Young, J.F. Lai, J. Holmstrom, D. Ream-Robinson, B.L. Cabrera, J.M. Carethers, Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR). Oncogene 29, 2172-2180 (2010)
38. J.M. Cunningham, E.R. Christensen, D.J. Tester, C.Y. Kim, P.C. Roche, L.J. Burgart, S.N. Thibodeau, Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455-3460 (1998) (Pubitemid 28371090)
39. A. de la Chapelle, H. Hampel, Clinical relevance of microsatellite instability in colorectal cancer. J. Clin. Oncol. 28, 3380-3387 (2010)
40. W.H. de Vos Test, Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer 109, 468-471 (2004)
41. N. de Wind, M. Dekker, N. Claij, L. Jansen, Y. van Klink, M. Radman, G. Riggins, M. van der Valk, K. van't Wout, H. te Riele, HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat Genet 23, 359-362 (1999) (Pubitemid 29526438)
42. G. Deng, I. Bell, S. Crawley, J. Gum, J.P. Terdiman, B.A. Allen, B. Truta, M.H. Sleisenger, Y.S. Kim, BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin. Cancer Res. 10, 191-195 (2004) (Pubitemid 38114179)
43. S. Derks, C. Postma, B. Carvalho, S.M. van den Bosch, P.T. Moerkerk, J.G. Herman, M.P. Weijenberg, A.P. de Bruine, G.A. Meijer, M. van Engeland, Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29, 434-439 (2008) (Pubitemid 351359685)
44. G. des Guetz, P. Mariani, J. Cucherousset, M. Benamoun, C. Lagorce, X. Sastre, P. Le Toumelin, B. Uzzan, G.Y. Perret, J.F. Morere, J.L. Breau, R. Fagard, P.O. Schischmanoff, Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res. 27(2007), 2715-2719 (2007) (Pubitemid 47227987)
45. G. des Guetz, O. Schischmanoff, P. Nicolas, G.Y. Perret, J.F. Morere, B. Uzzan, Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur. J. Cancer 45, 1890-1896 (2009)
46. G. des Guetz, B. Uzzan, P. Nicolas, O. Schischmanoff, G.Y. Perret, J.F. Morere, Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis. Anticancer Res. 29, 1615-1620 (2009)
47. E. Domingo, P. Laiho, M. Ollikainen, M. Pinto, L. Wang, A.J. French, J. Westra, T. Frebourg, E. Espin, M. Armengol, R. Hamelin, H. Yamamoto, R.M. Hofstra, R. Seruca, A. Lindblom, P. Peltomaki, S.N. Thibodeau, L.A. Aaltonen, S. Schwartz Jr., BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J. Med. Genet. 41, 664-668 (2004) (Pubitemid 39208606)
48. A. Duval, R. Hamelin, Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 62, 2447-2454 (2002) (Pubitemid 34462716)
49. A. Duval, S. Rolland, A. Compoint, E. Tubacher, B. Iacopetta, G. Thomas, R. Hamelin, Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum. Mol. Genet. 10, 513-518 (2001) (Pubitemid 32181674)
50. W. Edelmann, P.E. Cohen, B. Kneitz, N. Winand, M. Lia, J. Heyer, R. Kolodner, J.W. Pollard, R. Kucherlapati, Mammalian MutS homologue 5 is required for chromosome pairing in meiosis. Nat. Genet. 21, 123-127 (1999) (Pubitemid 29036298)
51. W. Edelmann, A. Umar, K. Yang, J. Heyer, M. Kucherlapati, M. Lia, B. Kneitz, E. Avdievich, K. Fan, E. Wong, G. Crouse, T. Kunkel, M. Lipkin, R.D. Kolodner, R. Kucherlapati, The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res. 60, 803-807 (2000) (Pubitemid 30129505)
52. H. Elsaleh, D. Joseph, F. Grieu, N. Zeps, N. Spry, B. Iacopetta, Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355, 1745-1750 (2000) (Pubitemid 30265078)
53. H. Elsaleh, B. Powell, K. McCaul, F. Grieu, R. Grant, D. Joseph, B. Iacopetta, P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin. Cancer Res. 7, 1343-1349 (2001) (Pubitemid 32708690)
54. H. Elsaleh, B. Shannon, B. Iacopetta, Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy. Gastroenterology 120, 1309-1310 (2001) (Pubitemid 32246688)
55. D. Fallik, F. Borrini, V. Boige, J. Viguier, S. Jacob, C. Miquel, J. C. Sabourin, M. Ducreux, F. Praz, Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res. 63, 5738-5744 (2003) (Pubitemid 37187470)
56. A. Fedier, V.A. Schwarz, H. Walt, R.D. Carpini, U. Haller, D. Fink, Resistance to topoisomerase poisons due to loss of DNA mismatch repair. Int. J. Cancer 93, 571-576 (2001) (Pubitemid 32701417)
57. D. Fink, S. Nebel, S. Aebi, H. Zheng, B. Cenni, A. Nehme, R.D. Christen, S.B. Howell, The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56, 4881-4886 (1996) (Pubitemid 26374423)
58. D. Fink, H. Zheng, S. Nebel, P.S. Norris, S. Aebi, T.P. Lin, A. Nehme, R.D. Christen, M. Haas, C.L. MacLeod, S.B. Howell, In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57, 1841-1845 (1997) (Pubitemid 27209707)
59. R. Fishel, M.K. Lescoe, M.R. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, R. Kolodner, The human mutatorgene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027-1038 (1993) (Pubitemid 24014559)
60. H. Flores-Rozas, R.D. Kolodner, The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations. Proc. Natl Acad. Sci. USA 95, 12404-12409 (1998) (Pubitemid 28483778)
61. R. Gafa, I. Maestri, M. Matteuzzi, A. Santini, S. Ferretti, L. Cavazzini, G. Lanza, Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer 89, 2025-2037 (2000)
62. L. Galio, C. Bouquet, P. Brooks, ATP hydrolysis-dependent formation of a dynamic ternary nucleoprotein complex with MutS and MutL. Nucleic Acids Res. 27, 2325-2331 (1999) (Pubitemid 29245651)
63. J. Genschel, S.J. Littman, J.T. Drummond, P. Modrich, Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J. Biol. Chem. 273, 19895-19901 (1998) (Pubitemid 28367056)
64. G. Giannini, C. Rinaldi, E. Ristori, M.I. Ambrosini, F. Cerignoli, A. Viel, E. Bidoli, S. Berni, G. D'Amati, G. Scambia, L. Frati, I. Screpanti, A. Gulino, Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene 23, 2640-2647 (2004) (Pubitemid 38586317)
65. G. Giannini, E. Ristori, F. Cerignoli, C. Rinaldi, M. Zani, A. Viel, L. Ottini, M. Crescenzi, S. Martinotti, M. Bignami, L. Frati, I. Screpanti, A. Gulino, Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 3, 248-254 (2002) (Pubitemid 34269518)
66. A. Goel, C.N. Arnold, D. Niedzwiecki, J.M. Carethers, J.M. Dowell, L. Wasserman, C. Compton, R.J. Mayer, M.M. Bertagnolli, C.R. Boland, Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 64, 3014-3021 (2004) (Pubitemid 38581399)
67. A. Goel, T. Nagasaka, C.N. Arnold, T. Inoue, C. Hamilton, D. Niedzwiecki, C. Compton, R.J. Mayer, R. Goldberg, M.M. Bertagnolli, C.R. Boland, The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132, 127-138 (2007) (Pubitemid 46108731)
68. J.K. Greenson, S.C. Huang, C. Herron, V. Moreno, J.D. Bonner, L.P. Tomsho, O. Ben-Izhak, H.I. Cohen, P. Trougouboff, J. Bejhar, Y. Sova, M. Pinchev, G. Rennert, S.B. Gruber, Pathologic predictors of microsatellite instability in colorectal cancer. Am. J. Surg. Pathol. 33, 126-133 (2009)
69. S. Grover, E.M. Stoffel, R.C. Mercado, B.M. Ford, W.K. Kohlman, K.M. Shannon, P.G. Conrad, A.M. Blanco, J.P. Terdiman, S.B. Gruber, D.C. Chung, S. Syngal, Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J. Clin. Oncol. 27, 3981-3986 (2009)
70. R. Gryfe, H. Kim, E.T. Hsieh, M.D. Aronson, E.J. Holowaty, S. B. Bull, M. Redston, S. Gallinger, Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342, 69-77 (2000) (Pubitemid 30036597)
71. C. Guastadisegni, M. Colafranceschi, L. Ottini, E. Dogliotti, Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur. J. Cancer 46, 2788-2798 (2010)
72. G. Hall, A. Clarkson, A. Shi, E. Langford, H. Leung, R.P. Eckstein, A.J. Gill, Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology 42, 409-413 (2010)
73. K.C. Halling, A.J. French, S.K. McDonnell, L.J. Burgart, D.J. Schaid, B.J. Peterson, L. Moon-Tasson, M.R. Mahoney, D.J. Sargent, M.J. O'Connell, T.E. Witzig, G.H. Farr Jr., R.M. Goldberg, S.N. Thibodeau, Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J. Natl Cancer Inst. 91, 1295-1303 (1999) (Pubitemid 29387571)
74. H. Hampel, W.L. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, M. Clendenning, K. Sotamaa, T. Prior, J.A. Westman, J. Panescu, D. Fix, J. Lockman, J. LaJeunesse, I. Comeras, A. de la Chapelle, Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J. Clin. Oncol. 26, 5783-5788 (2008)
75. H. Hampel, J.A. Stephens, E. Pukkala, R. Sankila, L.A. Aaltonen, J.P. Mecklin, A. de la Chapelle, Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129, 415-421 (2005) (Pubitemid 41096629)
76. B.D. Harfe, S. Jinks-Robertson, DNA mismatch repair and genetic instability. Annu. Rev. Genet. 34, 359-399 (2000) (Pubitemid 32065926)
77. N.J. Hawkins, R.L. Ward, Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J. Natl Cancer Inst. 93, 1307-1313 (2001) (Pubitemid 32910571)
78. A. Hemminki, J.P. Mecklin, H. Jarvinen, L.A. Aaltonen, H. Joensuu, Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119, 921-928 (2000)
79. P.M. Hempen, L. Zhang, R.K. Bansal, C.A. Iacobuzio-Donahue, K.M. Murphy, A. Maitra, B. Vogelstein, R.H. Whitehead, S.D. Markowitz, J.K. Willson, C.J. Yeo, R.H. Hruban, S.E. Kern, Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res. 63, 994-999 (2003) (Pubitemid 36278430)
80. Y.M. Hendriks, A. Wagner, H. Morreau, F. Menko, A. Stormorken, F. Quehenberger, L. Sandkuijl, P. Moller, M. Genuardi, H. Van Houwelingen, C. Tops, M. Van Puijenbroek, P. Verkuijlen, G. Kenter, A. Van Mil, H. Meijers-Heijboer, G.B. Tan, M.H. Breuning, R. Fodde, J.T. Wijnen, A.H. Brocker-Vriends, H. Vasen, Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127, 17-25 (2004) (Pubitemid 38962270)
81. J.G. Herman, A. Umar, K. Polyak, J.R. Graff, N. Ahuja, J.P. Issa, S. Markowitz, J.K. Willson, S.R. Hamilton, K.W. Kinzler, M.F. Kane, R.D. Kolodner, B. Vogelstein, T.A. Kunkel, S.B. Baylin, Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 95, 6870-6875 (1998) (Pubitemid 28278073)
82. N.M. Hollingsworth, L. Ponte, C. Halsey, MSH5, a novel MutS homolog, facilitates meiotic reciprocal recombination between homologs in Saccharomyces cerevisiae but not mismatch repair. Genes Dev. 9, 1728-1739 (1995)
83. Y. Ionov, H. Yamamoto, S. Krajewski, J.C. Reed, M. Perucho, Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl Acad. Sci. USA 97, 10872-10877 (2000)
84. J.P. Issa, CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988-993 (2004)
85. S. Jacob, M. Aguado, D. Fallik, F. Praz, The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 61, 6555-6562 (2001) (Pubitemid 32783264)
86. S. Jacob, C. Miquel, A. Sarasin, F. Praz, Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines. Nucleic Acids Res. 33, 106-113 (2005) (Pubitemid 40276932)
87. M.A. Jenkins, S. Hayashi, A.M. O'Shea, L.J. Burgart, T.C. Smyrk, D. Shimizu, P.M. Waring, A.R. Ruszkiewicz, A.F. Pollett, M. Redston, M.A. Barker, J.A. Baron, G.R. Casey, J.G. Dowty, G.G. Giles, P. Limburg, P. Newcomb, J.P. Young, M.D. Walsh, S.N. Thibodeau, N.M. Lindor, L. Lemarchand, S. Gallinger, R.W. Haile, J.D. Potter, J.L. Hopper, J.R. Jass, Pathology features in Bethesdaguidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 133, 48-56 (2007) (Pubitemid 47039240)
88. S.Y. Jeong, K.H. Shin, J.H. Shin, J.L. Ku, Y.K. Shin, S.Y. Park, W.H. Kim, J.G. Park, Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers. Dis. Colon Rectum 46, 1069-1077 (2003)
89. J. Jiricny, M. Nystrom-Lahti, Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 10, 157-161 (2000) (Pubitemid 30182248)
90. R. Jover, A. Castells, X. Llor, M. Andreu, Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 55, 1819-1820 (2006)
91. R. Jover, P. Zapater, A. Castells, X. Llor, M. Andreu, J. Cubiella, F. Balaguer, L. Sempere, R.M. Xicola, L. Bujanda, J.M. Rene, J. Clofent, X. Bessa, J.D. Morillas, D. Nicolas-Perez, E. Pons, A. Paya, C. Alenda, The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur. J. Cancer 45, 365-373 (2009)
92. R. Jover, P. Zapater, A. Castells, X. Llor, M. Andreu, J. Cubiella, V. Pinol, R.M. Xicola, L. Bujanda, J.M. Rene, J. Clofent, X. Bessa, J.D. Morillas, D. Nicolas-Perez, A. Paya, C. Alenda, Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 55, 848-855 (2006) (Pubitemid 43764557)
93. S.H. Jun, T.G. Kim, C. Ban, DNA mismatch repair system. Classical and fresh roles. FEBS J 273, 1609-1619 (2006) (Pubitemid 43779815)
94. B. Jung, R.T. Doctolero, A. Tajima, A.K. Nguyen, T. Keku, R.S. Sandler, J.M. Carethers, Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 126, 654-659 (2004) (Pubitemid 38298312)
95. B.H. Jung, S.E. Beck, J. Cabral, E. Chau, B.L. Cabrera, A. Fiorino, E.J. Smith, M. Bocanegra, J.M. Carethers, Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology 132, 633-644 (2007) (Pubitemid 46274658)
96. F.A. Kadyrov, L. Dzantiev, N. Constantin, P. Modrich, Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126, 297-308 (2006) (Pubitemid 44092957)
97. T. Kambara, L.A. Simms, V.L. Whitehall, K.J. Spring, C.V. Wynter, M.D. Walsh, M.A. Barker, S. Arnold, A. McGivern, N. Matsubara, N. Tanaka, T. Higuchi, J. Young, J.R. Jass, B.A. Leggett, BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137-1144 (2004) (Pubitemid 38961968)
98. M.F. Kane, M. Loda, G.M. Gaida, J. Lipman, R. Mishra, H. Goldman, J.M. Jessup, R. Kolodner, Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808-811 (1997) (Pubitemid 27097998)
99. G.P. Kim, L.H. Colangelo, H.S. Wieand, S. Paik, I.R. Kirsch, N. Wolmark, C.J. Allegra, Prognostic and predictive roles of highdegree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J. Clin. Oncol. 25, 767-772 (2007) (Pubitemid 350002875)
100. J. Kim, Y. Hong, J. Lee, M. Ryu, H. Chang, S. Jang, M. Kim, C. Yu and D.S. Kim, Association between deficient mismatch repair system and efficacy to irinotecan containing first-line chemotherapy in patients with sporadic metastatic colorectal cancer. 2010 ASCO Annual Meeting Abstract 3579 (2010)
101. N.G. Kim, Y.R. Choi, M.J. Baek, Y.H. Kim, H. Kang, N.K. Kim, J.S. Min, H. Kim, Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res. 61, 36-38 (2001) (Pubitemid 32095695)
102. S.T. Kim, J. Lee, S.H. Park, J.O. Park, H.Y. Lim, W.K. Kang, J. Y. Kim, Y.H. Kim, D.K. Chang, P.L. Rhee, D.S. Kim, H. Yun, Y. B. Cho, H.C. Kim, S.H. Yun, H.K. Chun, W.Y. Lee and Y.S. Park, The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. Med. Oncol. (2009)
103. S.T. Kim, J. Lee, S.H. Park, J.O. Park, H.Y. Lim, W.K. Kang, J. Y. Kim, Y.H. Kim, D.K. Chang, P.L. Rhee, D.S. Kim, H. Yun, Y. B. Cho, H.C. Kim, S.H. Yun, W.Y. Lee, H.K. Chun, Y.S. Park, Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Cancer Chemother. Pharmacol. 66, 659-667 (2010)
104. E. Kondo, A. Horii, S. Fukushige, The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res. 29, 1695-1702 (2001) (Pubitemid 32427850)
105. M. Koopman, G.A. Kortman, L. Mekenkamp, M.J. Ligtenberg, N. Hoogerbrugge, N.F. Antonini, C.J. Punt, J.H. van Krieken, Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br. J. Cancer 100, 266-273 (2009)
106. J.P. Kuebler, H.S. Wieand, M.J. O'Connell, R.E. Smith, L.H. Colangelo, G. Yothers, N.J. Petrelli, M.P. Findlay, T.E. Seay, J.N. Atkins, J.L. Zapas, J.W. Goodwin, L. Fehrenbacher, R.K. Ramanathan, B.A. Conley, P.J. Flynn, G. Soori, L.K. Colman, E.A. Levine, K.S. Lanier, N. Wolmark, Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J. Clin. Oncol. 25, 2198-2204 (2007) (Pubitemid 46954643)
107. R.S. Lahue, K.G. Au, P. Modrich, DNA mismatch correction in a defined system. Science 245, 160-164 (1989) (Pubitemid 19193931)
108. C. Lamberti, S. Lundin, M. Bogdanow, C. Pagenstecher, N. Friedrichs, R. Buttner, T. Sauerbruch, Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int. J. Colorectal Dis. 22, 145-152 (2007) (Pubitemid 44964017)
109. G. Lanza, R. Gafa, A. Santini, I. Maestri, L. Guerzoni, L. Cavazzini, Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J. Clin. Oncol. 24, 2359-2367 (2006) (Pubitemid 46630668)
110. F.S. Leach, N.C. Nicolaides, N. Papadopoulos, B. Liu, J. Jen, R. Parsons, P. Peltomaki, P. Sistonen, L.A. Aaltonen, M. Nystrom-Lahti et al., Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215-1225 (1993) (Pubitemid 24006117)
111. K.A. Lewis, J. Bakkum-Gamez, R. Loewen, A.J. French, S.N. Thibodeau, W.A. Cliby, Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers. Genes Chromosom. Cancer 46, 1061-1068 (2007) (Pubitemid 47614540)
112. H.R. Li, E.I. Shagisultanova, K. Yamashita, Z. Piao, M. Perucho, S.R. Malkhosyan, Hypersensitivity of tumor cell lines with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin. Cancer Res. 64, 4760-4767 (2004) (Pubitemid 38924519)
113. J.T. Liang, K.C. Huang, H.S. Lai, P.H. Lee, Y.M. Cheng, H.C. Hsu, A.L. Cheng, C.H. Hsu, K.H. Yeh, S.M. Wang, C. Tang, K. J. Chang, High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection. Int. J. Cancer 101, 519-525 (2002)
114. A. Lievre, J.B. Bachet, D. Le Corre, V. Boige, B. Landi, J.F. Emile, J.F. Cote, G. Tomasic, C. Penna, M. Ducreux, P. Rougier, F. Penault-Llorca, P. Laurent-Puig, KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 66, 3992-3995 (2006)
115. N.M. Lindor, L.J. Burgart, O. Leontovich, R.M. Goldberg, J.M. Cunningham, D.J. Sargent, C. Walsh-Vockley, G.M. Petersen, M. D. Walsh, B.A. Leggett, J.P. Young, M.A. Barker, J.R. Jass, J. Hopper, S. Gallinger, B. Bapat, M. Redston, S.N. Thibodeau, Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 20, 1043-1048 (2002) (Pubitemid 34141849)
116. N.M. Lindor, K. Rabe, G.M. Petersen, R. Haile, G. Casey, J. Baron, S. Gallinger, B. Bapat, M. Aronson, J. Hopper, J. Jass, L. LeMarchand, J. Grove, J. Potter, P. Newcomb, J.P. Terdiman, P. Conrad, G. Moslein, R. Goldberg, A. Ziogas, H. Anton-Culver, M. de Andrade, K. Siegmund, S.N. Thibodeau, L.A.
117. T. Liu, H. Yan, S. Kuismanen, A. Percesepe, M.L. Bisgaard, M. Pedroni, P. Benatti, K.W. Kinzler, B. Vogelstein, M. Ponz de Leon, P. Peltomaki, A. Lindblom, The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 61, 7798-7802 (2001) (Pubitemid 33049367)
118. X. Llor, E. Pons, R.M. Xicola, A. Castells, C. Alenda, V. Pinol, M. Andreu, S. Castellvi-Bel, A. Paya, R. Jover, X. Bessa, A. Giros, A. Roca, M.A. Gassull, Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin. Cancer Res. 11, 7304-7310 (2005) (Pubitemid 41507688)
119. E. Loire, F. Praz, D. Higuet, P. Netter, G. Achaz, Hypermutability of genes in Homo sapiens due to the hosting of long mono-SSR. Mol. Biol. Evol. 26, 111-121 (2009)
120. R.A. Lothe, P. Peltomaki, G.I. Meling, L.A. Aaltonen, M. Nystrom-Lahti, L. Pylkkanen, K. Heimdal, T.I. Andersen, P. Moller, T.O. Rognum et al., Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 53, 5849-5852 (1993) (Pubitemid 24006146)
121. M.B. Loughrey, P.M. Waring, A. Tan, M. Trivett, S. Kovalenko, V. Beshay, M.A. Young, G. McArthur, A. Boussioutas, A. Dobrovic, Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer 6, 301-310 (2007) (Pubitemid 47175009)
122. H.T. Lynch, M.W. Shaw, C.W. Magnuson, A.L. Larsen, A.J. Krush, Hereditary factors in cancer. Study of two large midwestern kindreds. Arch. Intern. Med. 117, 206-212 (1966)
123. R. Magrini, M.R. Bhonde, M.L. Hanski, M. Notter, H. Scherubl, C.R. Boland, M. Zeitz, C. Hanski, Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int. J. Cancer 101, 23-31 (2002) (Pubitemid 34832993)
124. A. Malesci, L. Laghi, P. Bianchi, G. Delconte, A. Randolph, V. Torri, C. Carnaghi, R. Doci, R. Rosati, M. Montorsi, M. Roncalli, L. Gennari, A. Santoro, Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin. Cancer Res. 13, 3831-3839 (2007) (Pubitemid 47037588)
125. S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R.S. Fan, E. Zborowska, K.W. Kinzler, B. Vogelstein et al., Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995)
126. G. Marra, I. Iaccarino, T. Lettieri, G. Roscilli, P. Delmastro, J. Jiricny, G.T. Marsischky, S. Lee, J. Griffith, R.D. Kolodner, Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc. Natl Acad. Sci. USA 95, 8568-8573 (1998) (Pubitemid 28350528)
127. G.T. Marsischky, N. Filosi, M.F. Kane, R. Kolodner, Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev. 10, 407-420 (1996) (Pubitemid 26085996)
128. G.T. Marsischky, R.D. Kolodner, Biochemical characterization of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 complex and mispaired bases in DNA. J. Biol. Chem. 274, 26668-26682 (1999)
129. A. McGivern, C.V. Wynter, V.L. Whitehall, T. Kambara, K.J. Spring, M.D. Walsh, M.A. Barker, S. Arnold, L.A. Simms, B.A. Leggett, J. Young, J.R. Jass, Promoter hypermethylation frequency and BRAF mutations distinguish hereditary nonpolyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 3, 101-107 (2004) (Pubitemid 40645891)
130. M. Meyers, M.W. Wagner, H.S. Hwang, T.J. Kinsella, D.A. Boothman, Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res. 61, 5193-5201 (2001) (Pubitemid 32681553)
131. J.M. Michael-Robinson, A. Biemer-Huttmann, D.M. Purdie, M. D. Walsh, L.A. Simms, K.G. Biden, J.P. Young, B.A. Leggett, J. R. Jass, G.L. Radford-Smith, Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 48, 360-366 (2001) (Pubitemid 32269564)
132. C. Miquel, F. Borrini, S. Grandjouan, A. Auperin, J. Viguier, V. Velasco, P. Duvillard, F. Praz, J.C. Sabourin, Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. Am. J. Clin. Pathol. 123, 562-570 (2005) (Pubitemid 40418551)
133. C. Miquel, S. Jacob, S. Grandjouan, A. Aime, J. Viguier, J.C. Sabourin, A. Sarasin, A. Duval, F. Praz, Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene 26, 5919-5926 (2007)
134. P. Modrich, R. Lahue, Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65, 101-133 (1996) (Pubitemid 26250606)
135. P. Mongiat-Artus, C. Miquel, M. Van der Aa, O. Buhard, R. Hamelin, H. Soliman, C. Bangma, A. Janin, P. Teillac, T. van der Kwast, F. Praz, Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 25, 2113-2118 (2006)
136. C.I. Muller, K. Schulmann, A. Reinacher-Schick, N. Andre, D. Arnold, A. Tannapfel, H. Arkenau, S.A. Hahn, S.H. Schmoll, R. Porschen, W. Schmiegel, U. Graeven, Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group. Int. J. Colorectal Dis. 23, 1033-1039 (2008)
137. T. Nakagawa, A. Datta, R.D. Kolodner, I. Iaccarino, G. Marra, F. Palombo, J. Jiricny, Multiple functions of MutS-and MutLrelated heterocomplexes. Proc. Natl Acad. Sci. USA 96, 14186-14188 (1999) (Pubitemid 30000618)
138. N.C. Nicolaides, N. Papadopoulos, B. Liu, Y.F. Wei, K.C. Carter, S.M. Ruben, C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C. M. Fraser et al., Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371, 75-80 (1994) (Pubitemid 24277467)
139. M. Nystrom-Lahti, R. Parsons, P. Sistonen, L. Pylkkanen, L.A. Aaltonen, F.S. Leach, S.R. Hamilton, P. Watson, E. Bronson, R. Fusaro et al., Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am. J. Hum. Genet. 55, 659-665 (1994) (Pubitemid 24298964)
140. M. Nystrom-Lahti, P. Sistonen, J.P. Mecklin, L. Pylkkanen, L.A. Aaltonen, H. Jarvinen, J. Weissenbach, A. de la Chapelle, P. Peltomaki, Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc. Natl Acad. Sci. USA 91, 6054-6058 (1994) (Pubitemid 24188281)
141. V. O'Brien, R. Brown, Signalling cell cycle arrest and cell death through the MMR system. Carcinogenesis 27, 682-692 (2006)
142. S. Ogino, K. Nosho, G.J. Kirkner, K. Shima, N. Irahara, S. Kure, A.T. Chan, J.A. Engelman, P. Kraft, L.C. Cantley, E.L. Giovannucci, C.S. Fuchs, PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J. Clin. Oncol. 27, 1477-1484 (2009)
143. L.I. Overbeek, M.J. Ligtenberg, R.W. Willems, R.P. Hermens, W.A. Blokx, S.V. Dubois, H. van der Linden, J.W. Meijer, M.L. Mlynek-Kersjes, N. Hoogerbrugge, K.M. Hebeda, J.H. van Krieken, Interpretation of immunohistochemistry for mismatchrepair proteins is only reliable in a specialized setting. Am. J. Surg. Pathol. 32, 1246-1251 (2008)
144. F. Palombo, I. Iaccarino, E. Nakajima, M. Ikejima, T. Shimada, J. Jiricny, hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 6, 1181-1184 (1996) (Pubitemid 26368752)
145. R. Parsons, L.L. Myeroff, B. Liu, J.K. Willson, S.D. Markowitz, K.W. Kinzler, B. Vogelstein, Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55, 5548-5550 (1995)
146. T.M. Pawlik, C.P. Raut, M.A. Rodriguez-Bigas, Colorectal carcinogenesis: MSI-H versus MSI-L. Dis. Markers 20, 199-206 (2004) (Pubitemid 40173899)
147. P. Peltomaki, Lynch syndrome genes. Fam Cancer 4, 227-232 (2005) (Pubitemid 41242191)
148. P. Peltomaki, L.A. Aaltonen, P. Sistonen, L. Pylkkanen, J.P. Mecklin, H. Jarvinen, J.S. Green, J.R. Jass, J.L. Weber, F.S. Leach et al., Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810-812 (1993) (Pubitemid 23167610)
149. P. Peltomaki, H. Vasen, Mutations associated with HNPCC predisposition-Update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers 20, 269-276 (2004) (Pubitemid 40164099)
150. S.M. Phillips, A. Banerjea, R. Feakins, S.R. Li, S.A. Bustin, S. Dorudi, Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br. J. Surg. 91, 469-475 (2004) (Pubitemid 38491119)
151. M. Pocard, R. Bras-Goncalves, R. Hamelin, J. Northover, M.F. Poupon, Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res. 20, 85-90 (2000) (Pubitemid 30189737)
152. S. Popat, R. Hubner, R.S. Houlston, Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609-618 (2005) (Pubitemid 46224239)
153. T.A. Prolla, DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10, 311-316 (1998) (Pubitemid 28287041)
154. M. Radman, R. Wagner, B.W. Glickman, Mismatch repair in Escherichia coli. Annu. Rev. Genet. 20, 523-538 (1986)
155. M. Raschle, G. Marra, M. Nystrom-Lahti, P. Schar, J. Jiricny, Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1. J. Biol. Chem. 274, 32368-32375 (1999)
156. C. Rayssiguier, D.S. Thaler, M. Radman, The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 342, 396-401 (1989) (Pubitemid 19277515)
157. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg, S.R. Hamilton, P. Laurent-Puig, R. Gryfe, L.E. Shepherd, D. Tu, M. Redston, S. Gallinger, Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349, 247-257 (2003) (Pubitemid 36859476)
158. R. Rodriguez, L.T. Hansen, G. Phear, J. Scorah, M. Spang-Thomsen, A. Cox, T. Helleday, M. Meuth, Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11. Clin. Cancer Res. 14, 5476-5483 (2008)
159. R. Roman, M. Verdu, M. Calvo, A. Vidal, X. Sanjuan, M. Jimeno, A. Salas, J. Autonell, I. Trias, M. Gonzalez, B. Garcia, N. Rodon, X. Puig, Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model. Virchows Arch. 456, 533-541 (2010)
160. P. Ross-Macdonald, G.S. Roeder, Mutation of a meiosis-specific MutS homolog decreases crossing over but not mismatch correction. Cell 79, 1069-1080 (1994)
161. B. Rousseau, B. Chibaudel, J.B. Bachet, A.K. Larsen, C. Tournigand, C. Louvet, T. Andre, A. de Gramont, Stage II and stage III colon cancer: treatment advances and future directions. Cancer J. 16, 202-209 (2010)
162. S. Salahshor, U. Kressner, H. Fischer, G. Lindmark, B. Glimelius, L. Pahlman, A. Lindblom, Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br. J. Cancer 81, 190-193 (1999) (Pubitemid 29423694)
163. P. Salama, M. Phillips, F. Grieu, M. Morris, N. Zeps, D. Joseph, C. Platell, B. Iacopetta, Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27, 186-192 (2009)
164. L.B. Saltz, D. Niedzwiecki, D. Hollis, R.M. Goldberg, A. Hantel, J.P. Thomas, A.L. Fields, R.J. Mayer, Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J. Clin. Oncol. 25, 3456-3461 (2007) (Pubitemid 47310883)
165. W.S. Samowitz, K. Curtin, K.N. Ma, D. Schaffer, L.W. Coleman, M. Leppert, M.L. Slattery, Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev. 10, 917-923 (2001) (Pubitemid 32844897)
166. D.J. Sargent, S. Marsoni, G. Monges, S.N. Thibodeau, R. Labianca, S.R. Hamilton, A.J. French, B. Kabat, N.R. Foster, V. Torri, C. Ribic, A. Grothey, M. Moore, A. Zaniboni, J.F. Seitz, F. Sinicrope and S. Gallinger, Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. (2010)
167. P. Schweizer, A.L. Moisio, S.A. Kuismanen, K. Truninger, R. Vierumaki, R. Salovaara, J. Arola, R. Butzow, J. Jiricny, P. Peltomaki, M. Nystrom-Lahti, Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer. Cancer Res. 61, 2813-2815 (2001) (Pubitemid 32691916)
168. Y. Schwitalle, M. Kloor, S. Eiermann, M. Linnebacher, P. Kienle, H.P. Knaebel, M. Tariverdian, A. Benner, M. von Knebel Doeberitz, Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134, 988-997 (2008) (Pubitemid 351459601)
169. S.N. Shah, S.E. Hile, K.A. Eckert, Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Res. 70, 431-435 (2010)
170. J. Shia, L.H. Tang, E. Vakiani, J.G. Guillem, Z.K. Stadler, R.A. Soslow, N. Katabi, M.R. Weiser, P.B. Paty, L.K. Temple, G.M. Nash, W.D. Wong, K. Offit, D.S. Klimstra, Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am. J. Surg. Pathol. 33, 1639-1645 (2009)
171. F.A. Sinicrope, DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat. Rev. Clin. Oncol. 7, 174-177 (2010)
172. F.A. Sinicrope, R.L. Rego, M.M. Garrity-Park, N.R. Foster, D.J. Sargent, R.M. Goldberg, M. Wiesenfeld, T.E. Witzig, S.N. Thibodeau, L.J. Burgart, Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability. Int. J. Cancer 120, 1232-1238 (2007)
173. F.A. Sinicrope, R.L. Rego, K.C. Halling, N. Foster, D.J. Sargent, B. La Plant, A.J. French, J.A. Laurie, R.M. Goldberg, S.N. Thibodeau, T.E. Witzig, Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131, 729-737 (2006) (Pubitemid 44307064)
174. E. Stoffel, B. Mukherjee, V.M. Raymond, N. Tayob, F. Kastrinos, J. Sparr, F. Wang, P. Bandipalliam, S. Syngal, S.B. Gruber, Calculation of risk of colorectal and endometrial canceramong patients with Lynch syndrome. Gastroenterology 137, 1621-1627 (2009)
175. L. Stojic, R. Brun, J. Jiricny, Mismatch repair and DNA damage signalling. DNA Repair (Amst.) 3, 1091-1101 (2004) (Pubitemid 38997952)
176. N. Sugawara, F. Paques, M. Colaiacovo, J.E. Haber, Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination. Proc. Natl Acad. Sci. USA 94, 9214-9219 (1997) (Pubitemid 27357809)
177. H. Takemura, V.A. Rao, O. Sordet, T. Furuta, Z.H. Miao, L. Meng, H. Zhang, Y. Pommier, Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks. J. Biol. Chem. 281, 30814-30823 (2006) (Pubitemid 44582136)
178. J.P. Terdiman, J.R. Gum Jr., P.G. Conrad, G.A. Miller, V. Weinberg, S.C. Crawley, T.R. Levin, C. Reeves, A. Schmitt, M. Hepburn, M.H. Sleisenger, Y.S. Kim, Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 120, 21-30 (2001) (Pubitemid 32061865)
179. S.N. Thibodeau, G. Bren, D. Schaid, Microsatellite instability in cancer of the proximal colon. Science 260, 816-819 (1993) (Pubitemid 23167612)
180. A. Umar, C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, S. Srivastava, Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl Cancer Inst. 96, 261-268 (2004) (Pubitemid 38256271)
181. A. Vaisman, M. Varchenko, A. Umar, T.A. Kunkel, J.I. Risinger, J.C. Barrett, T.C. Hamilton, S.G. Chaney, The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58, 3579-3585 (1998) (Pubitemid 28376554)
182. E. Van Cutsem, R. Labianca, G. Bodoky, C. Barone, E. Aranda, B. Nordlinger, C. Topham, J. Tabernero, T. Andre, A.F. Sobrero, E. Mini, R. Greil, F. Di Costanzo, L. Collette, L. Cisar, X. Zhang, D. Khayat, C. Bokemeyer, A.D. Roth, D. Cunningham, Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J. Clin. Oncol. 27, 3117-3125 (2009)
183. H.F. Vasen, J.P. Mecklin, P.M. Khan, H.T. Lynch, The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 34, 424-425 (1991)
184. H.F. Vasen, G. Moslein, A. Alonso, S. Aretz, I. Bernstein, L. Bertario, I. Blanco, S. Bulow, J. Burn, G. Capella, C. Colas, C. Engel, I. Frayling, N. Rahner, F.J. Hes, S. Hodgson, J.P. Mecklin, P. Moller, T. Myrhoj, F.M. Nagengast, Y. Parc, M. Ponz de Leon, L. Renkonen-Sinisalo, J.R. Sampson, A. Stormorken, S. Tejpar, H.J. Thomas, J. Wijnen, J. Lubinski, H. Jarvinen, E. Claes, K. Heinimann, J.A. Karagiannis, A. Lindblom, I. Dove-Edwin, H. Muller, Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9, 109-115 (2010)
185. H.F. Vasen, G. Moslein, A. Alonso, I. Bernstein, L. Bertario, I. Blanco, J. Burn, G. Capella, C. Engel, I. Frayling, W. Friedl, F.J. Hes, S. Hodgson, J.P. Mecklin, P. Moller, F. Nagengast, Y. Parc, L. Renkonen-Sinisalo, J.R. Sampson, A. Stormorken, J. Wijnen, Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet. 44, 353-362 (2007) (Pubitemid 46953715)
186. H.F. Vasen, P. Watson, J.P. Mecklin, H.T. Lynch, New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116, 1453-1456 (1999) (Pubitemid 29258894)
187. V. Vassileva, A. Millar, L. Briollais, W. Chapman, B. Bapat, Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Res. 62, 4095-4099 (2002) (Pubitemid 34791080)
188. S. Velho, C. Oliveira, A. Ferreira, A.C. Ferreira, G. Suriano, S. Schwartz Jr., A. Duval, F. Carneiro, J.C. Machado, R. Hamelin, R. Seruca, The prevalence of PIK3CA mutations in gastric and colon cancer. Eur. J. Cancer 41, 1649-1654 (2005) (Pubitemid 40981849)
189. E. Vilar, S.B. Gruber, Microsatellite instability in colorectal cancer-The stable evidence. Nat. Rev. Clin. Oncol. 7, 153-162 (2010)
190. E. Vilar, M. Scaltriti, J. Balmana, C. Saura, M. Guzman, J. Arribas, J. Baselga, J. Tabernero, Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines. Br. J. Cancer 99, 1607-1612 (2008)
191. A. Walther, R. Houlston, I. Tomlinson, Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57, 941-950 (2008) (Pubitemid 351919529)
192. L. Wang, J.M. Cunningham, J.L. Winters, J.C. Guenther, A.J. French, L.A. Boardman, L.J. Burgart, S.K. McDonnell, D.J. Schaid, S.N. Thibodeau, BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res. 63, 5209-5212 (2003) (Pubitemid 37139829)
193. R. Ward, A. Meagher, I. Tomlinson, T. O'Connor, M. Norrie, R. Wu, N. Hawkins, Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48, 821-829 (2001) (Pubitemid 32476985)
194. A.S. Warthin, Heredity with reference to carcinoma. Arch. Intern. Med. 12, 546-555 (1913)
195. P. Watson, H.F. Vasen, J.P. Mecklin, I. Bernstein, M. Aarnio, H.J. Jarvinen, T. Myrhoj, L. Sunde, J.T. Wijnen, H.T. Lynch, The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int. J. Cancer 123, 444-449 (2008) (Pubitemid 351842032)
196. D.J. Weisenberger, K.D. Siegmund, M. Campan, J. Young, T.I. Long, M.A. Faasse, G.H. Kang, M. Widschwendter, D. Weener, D. Buchanan, H. Koh, L. Simms, M. Barker, B. Leggett, J. Levine, M. Kim, A.J. French, S.N. Thibodeau, J. Jass, R. Haile, P.W. Laird, CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787-793 (2006) (Pubitemid 43980599)
197. K.M. Welsh, A.L. Lu, S. Clark, P. Modrich, Isolation and characterization of the Escherichia coli mutH gene product. J. Biol. Chem. 262, 15624-15629 (1987)
198. J.L. Westra, M. Schaapveld, H. Hollema, J.P. de Boer, M.M. Kraak, D. de Jong, A. ter Elst, N.H. Mulder, C.H. Buys, R.M. Hofstra, J.T. Plukker, Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-Treated stage III colon cancer patients. J. Clin. Oncol. 23, 5635-5643 (2005)
199. S.M. Woerner, A. Benner, C. Sutter, M. Schiller, Y.P. Yuan, G. Keller, P. Bork, M.K. Doeberitz, J.F. Gebert, Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 22, 2226-2235 (2003) (Pubitemid 36566779)
200. S.M. Woerner, Y.P. Yuan, A. Benner, S. Korff, M. von Knebel Doeberitz, P. Bork, SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology. Nucleic Acids Res. 38, D682-689 (2010)
201. C.M. Wright, O.F. Dent, M. Barker, R.C. Newland, P.H. Chapuis, E.L. Bokey, J.P. Young, B.A. Leggett, J.R. Jass, G.A. Macdonald, Prognostic significance of extensive microsatelliteinstability in sporadic clinicopathological stage C colorectal cancer. Br. J. Surg. 87, 1197-1202 (2000)
202. M. Yamada, E. O'Regan, R. Brown, P. Karran, Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucleic Acids Res. 25, 491-496 (1997)
203. A. Zaanan, P. Cuilliere-Dartigues, A. Guilloux, Y. Parc, C. Louvet, A. de Gramont, E. Tiret, S. Dumont, B. Gayet, P. Validire, J.F. Flejou, A. Duval, F. Praz, Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann. Oncol. 21, 772-780 (2010)
204. Z.Z. Zdraveski, J.A. Mello, C.K. Farinelli, J.M. Essigmann, M. G. Marinus, MutS preferentially recognizes cisplatin-over oxaliplatin-modified DNA. J. Biol. Chem. 277, 1255-1260 (2002) (Pubitemid 34968877)